BioTelemetry Inc. (BEAT)

41.40
0.44 1.10
NASDAQ : Health Technology
Prev Close 40.96
Open 41.44
Day Low/High 41.03 / 41.83
52 Wk Low/High 38.78 / 80.92
Volume 179.28K
Avg Volume 385.20K
Exchange NASDAQ
Shares Outstanding 33.89M
Market Cap 1.39B
EPS 1.30
P/E Ratio 32.07
Div & Yield N.A. (N.A)

Latest News

BioTelemetry, Inc. Reports Second Quarter 2019 Financial Results

BioTelemetry, Inc. Reports Second Quarter 2019 Financial Results

Exceeds Expectations Achieves Record Revenue and Adjusted EBITDA MALVERN, Pa., July 30, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc.

BioTelemetry, Inc. Acquires Sweden-based ADEA Medical AB And Expands International Service Offering

BioTelemetry, Inc. Acquires Sweden-based ADEA Medical AB And Expands International Service Offering

MALVERN, Pa., July 24, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc.

BioTelemetry, Inc. To Release Second Quarter 2019 Earnings Results On July 30, 2019

BioTelemetry, Inc. To Release Second Quarter 2019 Earnings Results On July 30, 2019

MALVERN, Pa., July 19, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc.

Notable Thursday Option Activity: BEAT, MBI, MCRN

Notable Thursday Option Activity: BEAT, MBI, MCRN

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in BioTelemetry Inc , where a total of 5,110 contracts have traded so far, representing approximately 511,000 underlying shares. That amounts to about 77.6% of BEAT's average daily trading volume over the past month of 658,470 shares.

First Week Of BEAT November 15th Options Trading

First Week Of BEAT November 15th Options Trading

Investors in BioTelemetry Inc saw new options begin trading this week, for the November 15th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

BEAT Crosses Above Average Analyst Target

BEAT Crosses Above Average Analyst Target

In recent trading, shares of BioTelemetry Inc have crossed above the average analyst 12-month target price of $75.00, changing hands for $76.50/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

BEAT Crosses Above Average Analyst Target

BEAT Crosses Above Average Analyst Target

In recent trading, shares of BioTelemetry Inc have crossed above the average analyst 12-month target price of $69.20, changing hands for $69.47/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Chart of the Day: BioTelemetry

With some follow-through over the next few sessions, we could see BEAT marching back to old highs.

You Can't Stop the BEAT

You Can't Stop the BEAT

It's hard to find a better-trending stock chart than BioTelemetry.

Chart of the Day: BioTelemetry

BEAT is up a stunning 100% in just five months' time.

Notable Tuesday Option Activity: BEAT, VRA, NTNX

Notable Tuesday Option Activity: BEAT, VRA, NTNX

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in BioTelemetry Inc , where a total of 1,539 contracts have traded so far, representing approximately 153,900 underlying shares. That amounts to about 47.6% of BEAT's average daily trading volume over the past month of 323,310 shares.

December 2019 Options Now Available For BioTelemetry (BEAT)

December 2019 Options Now Available For BioTelemetry (BEAT)

Investors in BioTelemetry Inc saw new options begin trading today, for the December 2019 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 508 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

BioTelemetry Reaches Analyst Target Price

BioTelemetry Reaches Analyst Target Price

In recent trading, shares of BioTelemetry Inc have crossed above the average analyst 12-month target price of $52.00, changing hands for $53.70/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMCX, APAM, BEAT, BSX, CIO, CRZO, EFII, FNB, LNDC, NTWK, OXSQ, SIR, VOC, WHG Downgrades: ABEV, ARNC, BMS, EMCI, ERII, ESGR, ESLT, GASS, IVZ, LPL, PICO Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Notable Thursday Option Activity: BEAT, JNCE, CAL

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in BioTelemetry Inc , where a total volume of 2,168 contracts has been traded thus far today, a contract volume which is representative of approximately 216,800 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 79.1% of BEAT's average daily trading volume over the past month, of 274,115 shares.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AIR, CIT, DAR, OFIX, YIN, ZUMZ Downgrades: ALO, BEAT, HK, NMIH, OSTK, PM, WBA Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Short Interest In BioTelemetry Makes 57.2% Move

Short Interest In BioTelemetry Makes 57.2% Move

The most recent short interest data has been released for the 12/29/2017 settlement date, which shows a 1,318,658 share increase in total short interest for BioTelemetry Inc , to 3,622,167, an increase of 57.25% since 12/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

First Week of BEAT August 2018 Options Trading

First Week of BEAT August 2018 Options Trading

Investors in BioTelemetry Inc saw new options begin trading this week, for the August 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

BioTelemetry Breaks Above 200-Day Moving Average - Bullish for BEAT

BioTelemetry Breaks Above 200-Day Moving Average - Bullish for BEAT

In trading on Monday, shares of BioTelemetry Inc crossed above their 200 day moving average of $30.75, changing hands as high as $30.85 per share. BioTelemetry Inc shares are currently trading up about 2.5% on the day.

Interesting BEAT Put And Call Options For January 2018

Interesting BEAT Put And Call Options For January 2018

Investors in BioTelemetry Inc saw new options become available this week, for the January 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BEAT options chain for the new January 2018 contracts and identified one put and one call contract of particular interest.

Oversold Conditions For BioTelemetry (BEAT)

Oversold Conditions For BioTelemetry (BEAT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

BioTelemetry Research And AMRA Raise The Standard For Medical Imaging In NASH/NAFLD Clinical Trials

BioTelemetry Research And AMRA Raise The Standard For Medical Imaging In NASH/NAFLD Clinical Trials

First to Market Alliance Increases Precision and Specificity while Reducing Cost

TheStreet Quant Rating: C+ (Hold)